One study showed that the expressions of miR-1, miR-20a, miR-28, miR-95, miR-146a, miR-335, and miR-625 in the PBMC of pregnant MS patients were downregulated, while the levels of IL10, PDL1, and PDL2 were increased compared with untreated MS patients. Here, IL10 is linked to myeloid sarcoma.